551-560 of 667 results

The ending point for 'starting point'
Insight 01 Sep 2014

The Full Federal Court has published its much-anticipated judgment in the AstraZeneca v Apotex appeal A bench of five judges heard the appeal in contrast to the usual three judges in order to be able to clarify or overrule if appropriate an earlier Full Court decision relating to the correct test ...

Not quite business as usual - IP Australia takes pragmatic view of Myriad
Insight 19 Oct 2015

IP Australia has taken a pragmatic approach to the Myriad decision that will give comfort to Australias biotechnology industry and research organisations that they can continue to carry out biological RD and be able to obtain patent protection for innovation in Australia Partner Dr Trevor Davies ...

Fact sheet: Growing your team: working with interns in your startup
Insight 28 Jul 2015

Many startups look to grow their team by engaging interns work experience students and other unpaid workers ...

NSW to go it alone on a tort of privacy?
Insight 11 Mar 2016

A New South Wales legislative committee has released a report following an inquiry into remedies for serious invasions of privacy in New South Wales In an unexpected and controversial move the report recommends that the NSW Government take the lead by introducing a statutory cause of action for ...

Commissioner threatens to issue higher tax bills
Insight 19 Feb 2016

The Commissioner of Taxation has in a recent Australian Senate Estimates hearing expressed frustration that companies potentially subject to Australias cross-border anti-avoidance laws including the new Multinational Anti-Avoidance Law or MAAL which have documents offshore outside the reach of his ...

Allens Accelerate: The startup investor tax concessions - what you need to know
Insight 22 Mar 2016

The Federal Government has introduced a Bill detailing tax concessions to incentivise investment into Australian startups ...

Assessment of biosimilars - Is Australia leading, following or going its own way?
Insight 26 Oct 2016

The ongoing lack of certainty about what is required to obtain biosimilar registration in Australia extends to three key issues - Comparability is the new product sufficiently similar to permit it to rely on the reference products safety and efficacy data Extrapolation for which of the indications ...

Insuring against cyber-risks: a changing landscape
Insight 23 Jul 2015

As cyber-attacks on Australian businesses increase many companies are discovering they are not adequately prepared or insured to handle a cyber-attack ...

Fact sheet: The term sheet decoded
Insight 24 Sep 2015

The term sheet is the key document that determines the basis on which VCs and other investors will invest in your startup This means that its crucial to get the basics right from the outset ...

Allens Accelerate: Preparing for investment
Insight 08 Jun 2016

As a startup looking to raise capital youll most likely spend a fair bit of time thinking about your pitch to potential investors and if youre lucky the terms of any investment ...

Refine